CRF and Related Peptides as Anti‐Inflammatory Agonists

Annals of the New York Academy of Sciences

Volumn 697, Issue 1, 1993, Pages 219-228

  THOMAS, H A ^a   LING, N ^b   WEI, E T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Whittier Institute for Diabetes   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; GLUTAMIC ACID; NEUROPEPTIDE;

AMINO ACID SUBSTITUTION; ANIMAL EXPERIMENT; ANIMAL MODEL; BINDING SITE; BLOOD VESSEL PERMEABILITY; CARBOXY TERMINAL SEQUENCE; CONFERENCE PAPER; CONTROLLED STUDY; CORTICOTROPIN RELEASE; CYTOSKELETON; ENDOTHELIUM CELL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INFLAMMATION; INTERMEDIATE FILAMENT; MUCOSA; NONHUMAN; PAIN; PEPTIDE SYNTHESIS; PROTEIN STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; SENSORY NERVE; STRESS; TISSUE INJURY;

ANIMALIA;

EID: 0027739375     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1993.tb49934.x     Document Type: Article

References (32)

1. Anti‐inflammatory peptide agonists
2. Peripheral anti‐inflammatory actions of CRF
3. Inflammation and repair
4. Peptides of the corticoliberin superfamily inhibit thermal and neurogenic inflammation
5. Corticotropin‐releasing factor: An inhibitor of vascular leakage in rat skeletal muscle and brain cortex after injury
6. Corticotropin‐releasing factor inhibits thermal injury
7. Decreased inflammatory responsiveness of hypophysectomized rats to heat is reversed by a corticotropin‐releasing factor (CRF) antagonist
8. Epinephrine‐induced pulmonary edema in rats is inhibited by corticotropin‐releasing factor
9. Synthetic competitive antagonists of corticotropin‐releasing factor: Effect on ACTH secretion in the rat
10. Corticotropin‐releasing factor inhibits neurogenic plasma extravasation in the rat paw
11. Corticotropin‐releasing factor (CRF) produces analgesia in humans and rats
12. Corticotropin‐releasing factor inhibits the response of trigeminal neurons to noxious heat
13. Substance P as a neurogenic mediator of antidromic vasodilitation and neurogenic plasma extravasation
14. Mechanism for the anti‐inflammatory effect of corticotropin‐releasing factor (CRF)
15. 125I]Tyr‐corticotropin‐releasing factor to rabbit aorta is reduced by removal of the endothelium
16. Corticotropin‐releasing factor inhibition of substance P‐induced vascular leakage in rats: Possible sites of action
17. The cDNA sequence of a type II cytoskeletal keratin reveals constant and variable structural domains among keratins
18. The structure of the vimentin gene
19. Intermediate filaments: A review of the basic biology
20. Modulation of pulmonary permeability in vivo with agents that effect the cytoskeleton
21. Cytokeratin filament modulation in pulmonary microvascular endothelial cells by vasoactive agents and culture confluency
22. Do the ends justify the mean? Proline mutations at the ends of the keratin coiled‐coil rod segment are more disruptive than internal mutations
23. Solid phase peptide synthesis. I. The synthesis of a tetrapeptide
24. 1]plasminogen by tissue plasminogen activator and retards fibrin polymerization
25. A simplified method of evaluating dose‐effect experiments
26. Characterization of a 41‐residue ovine hypothalamic peptide that stimulates secretion of corticotropin and β‐endorphin
27. Physiology and pharmacology of corticotropin‐releasing factor
28. Differential antagonist activity of alpha‐helical corticotropin‐releasing factor 9‐41 in three bioassay systems
29. Release from inflamed tissue of a substance with properties similar to corticotropin‐releasing factor
30. Autocrine or paracrine inflammatory actions of corticotropin‐releasing hormone in vivo